Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 18.

Barthelmes, D; Walton, R; Campain, A E; Simpson, J M; Arnold, J J; McAllister, I L; Guymer, R H; Hunyor, R H; Essex, R W; Morlet, N; Gillies, M C (2015). Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data. The British Journal of Ophthalmology, 99(3):359-364.

Gillies, M C; Campain, A; Walton, R; Simpson, J M; Arnold, J J; Guymer, R H; McAllister, I L; Hunyor, A P; Essex, R W; Morlet, N; Barthelmes, D (2015). Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab. Ophthalmology, 122(3):589-594.e1.

Gillies, M C; Walton, R J; Arnold, J J; McAllister, I L; Simpson, J M; Hunyor, A P; Guymer, R; Essex, R W; Moriet, N; Barthelmes, D (2014). Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort. Ophthalmology, 121(3):676-681.

Barthelmes, D; Zhu, L; Shen, W; Gillies, M C; Irhimeh, M R (2014). Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice. Cardiovascular Diabetology, 13:42.

Gillies, M C; Walton, R; Liong, J; Arnold, J J; McAllister, I; Morlet, N; Hunyor, A; Guymer, R; Keeffe, J; Essex, R; Herrera-Bond, A; Glastonbury, B; Simpson, J M; Barthelmes, D (2014). Efficient capture of high-quality data on outcomes of treatment for macular diseases: The Fight Retinal Blindness! Project. Retina, 34(1):188-195.

Barthelmes, D; Walton, R J; Arnold, J J; McAllister, I L; Simpson, J M; Campain, A; Hunyor, A P; Guymer, R; Essex, R W; Morlet, N; Gillies, M C (2014). Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration. Ophthalmology, 121(10):2073-2074.

O'Day, R; Walton, R; Blennerhassett, R; Gillies, M C; Barthelmes, D (2014). Reporting of harms by randomised controlled trials in ophthalmology. The British Journal of Ophthalmology, 98(8):1003-1008.

Gillies, M C; Walton, R; Simpson, J M; Arnold, J; Guymer, R H; McAllister, I L; Hunyor, A P; Essex, R W; Morlet, N; Barthelmes, D (2013). Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes. Investigative Ophthalmology & Visual Science [IOVS], 54(8):5754-5760.

Barthelmes, D; Irhimeh, M R; Gillies, M C; Zhu, L; Shen, W (2013). Isolation and characterization of mouse bone marrow-derived Lin-/VEGF-R2 + progenitor cells. Annals of Hematology, 92(11):1461-1472.

Zhu, L; Shen, W; Zhu, M; Coorey, N J; Nguyen, A P; Barthelmes, D; Gillies, M C (2013). Anti-retinal antibodies in patients with macular telangiectasia type 2. Investigative Ophthalmology & Visual Science [IOVS], 21(54):5675-5683.

O'Day, R; Barthelmes, D; Zhu, M; Wong, T Y; McAllister, I L; Arnold, J J; Gillies, M C (2013). Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema. Clinical Ophthalmology, 7:1565-1570.

Barthelmes, D; Irhimeh, M R; Gillies, M C; Karimipour, M; Zhou, M; Zhu, L; Shen, W Y (2013). Diabetes impairs mobilization of mouse bone marrow-derived Lin−/VEGF-R2+ progenitor cells. Blood Cells, Molecules & Diseases, 51(3):163-173.

Gillies, M C; Zhu, M; Chew, E; Barthelmes, D; Hughes, E; Ali, H; Holz, F G; Scholl, H P; Issa, P C (2009). Familial asymptomatic macular telangiectasia type 2. Ophthalmology, 116(12):2422-2429.

Gillies, M C; Simpson, J M; Gaston, C; Hunt, G; Ali, H; Zhu, M; Sutter, F (2009). Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology, 116(11):2182-2187.

Larsson, J; Kifley, A; Zhu, M; Wang, J J; Mitchell, P; Sutter, F K; Gillies, M C (2009). Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. Acta Ophthalmologica, 87(3):275-280.

Fischer, M D; Fleischhauer, J C; Gillies, M C; Sutter, F K; Helbig, H; Barthelmes, D (2008). A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Investigative Ophthalmology and Visual Science, 49(8):3617-3621.

Barthelmes, D; Sutter, F K P; Gillies, M C (2008). Differential optical densities of intraretinal spaces. Investigative Ophthalmology and Visual Science, 49(8):3529-3534.

Barthelmes, D; Gillies, M C; Sutter, F K P (2008). Quantitative OCT analysis of idiopathic perifoveal telangiectasia. Investigative Ophthalmology and Visual Science, 49(5):2156-2162.

This list was generated on Thu Jul 19 04:19:23 2018 CEST.